VIOLA, DAVID Statistiche
VIOLA, DAVID
5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I
2016-01-01 Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I
2015-01-01 Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R.
Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center
2017-01-01 Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora
Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center
2020-01-01 Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella
Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia
2021-01-01 Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R.
An idic(15) associated with POF (premature ovarian failure): Molecular cytogenetic definition of a case and review of the literature.
2012-01-01 Bertini, V; Viola, David; Vitti, Paolo; Simi, P; Valetto, A.
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
2013-01-01 Xing, M; Alzahrani, As; Carson, Ka; Viola, David; Elisei, Rossella; Bendlova, B; Yip, L; Mian, C; Vianello, F; Tuttle, Rm; Robenshtok, E; Fagin, Ja; Puxeddu, E; Fugazzola, L; Czarniecka, A; Jarzab, B; O'Neill, Cj; Sywak, Ms; Lam, Ak; Riesco Eizaguirre, G; Santisteban, P; Nakayama, H; Tufano, Rp; Pai, Si; Zeiger, Ma; Westra, Wh; Clark, Dp; Clifton Bligh, R; Sidransky, D; Ladenson, Pw; Sykorova, V.
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer
2015-01-01 Xing, Mingzhao; Alzahrani, Ali S.; Carson, Kathryn A.; Shong, Young Kee; Kim, Tae Yong; Viola, David; Elisei, Rossella; Bendlová, Bela; Yip, Linwah; Mian, Caterina; Vianello, Federica; Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.; Puxeddu, Efisio; Fugazzola, Laura; Czarniecka, Agnieszka; Jarzab, Barbara; O'Neill, Christine J.; Sywak, Mark S.; Lam, Alfred K.; Riesco Eizaguirre, Garcilaso; Santisteban, Pilar; Nakayama, Hirotaka; Clifton Bligh, Roderick; Tallini, Giovanni; Holt, Elizabeth H.; Sýkorová, Vlasta
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer
2015-01-01 Xing, Mingzhao; Alzahrani, Ali S.; Carson, Kathryn A.; Shong, Young Kee; Kim, Tae Yong; Viola, David; Elisei, Rossella; Bendlová, Bela; Yip, Linwah; Mian, Caterina; Vianello, Federica; Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.; Puxeddu, Efisio; Fugazzola, Laura; Czarniecka, Agnieszka; Jarzab, Barbara; O'Neill, Christine J.; Sywak, Mark S.; Lam, Alfred K.; Riesco Eizaguirre, Garcilaso; Santisteban, Pilar; Nakayama, Hirotaka; Clifton Bligh, Roderick; Tallini, Giovanni; Holt, Elizabeth H.; Sýkorová, Vlasta
Biological and molecular markers for diagnosis, follow-up and prognosis of patients affected by thyroid cancer.
2008-01-01 Elisei, Rossella; Viola, David; Pinchera, Aldo
BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer
2018-01-01 Wang, Fei; Zhao, Shihua; Shen, Xiaopei; Zhu, Guangwu; Liu, Rengyun; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O’Neill, Christine J.; Sywak, Mark S.; Clifton-Bligh, Roderick; Bendlova, Bela; Sýkorová, Vlasta; Wang, Yangang; Xing, Mingzhao
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment
2017-01-01 Huang, Yueye; Qu, Shen; Zhu, Guangwu; Wang, Fei; Liu, Rengyun; Shen, Xiaopei; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Neill, Christine J; Xing, Mingzhao; Sywak, Mark S; Clifton-Bligh, Roderick; Bendlova, Bela; Sýkorová, Vlasta
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
2020-01-01 Kim, K. J.; Kim, S. G.; Tan, J.; Shen, X.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Xing, M.
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer
2021-01-01 Tao, Y.; Wang, F.; Shen, X.; Zhu, G.; Liu, R.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Zhao, S.; Wang, Y.; Xing, M.
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study
2008-01-01 Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio
BRAF(V600E) mutations are correlated with a lower expression of both NIS and TPO mRNA expression in papillary thyroid cancer (PTC)
2007-01-01 Romei, C; Ciampi, R; Faviana, Pinuccia; Basolo, Fulvio; Bottici, V; Viola, David; Berti, P; Molinaro, E; Pinchera, A; Elisei, Rossella
BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
2007-01-01 Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella
BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study.
2012-01-01 Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella
Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST
2021-01-01 Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella
Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer.
2013-01-01 Viola, David; Cappagli, V; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 5 Years Follow Up Of Thyroglobulin (Tg), Thyroglobulin Antibodies (Tgab) And Neck Ultrasound (Nus) In Patients With Papillary Thyroid Microcarcinoma (Mptc) Treated With Total Thyroidectomy But Not Ablated With 131I | 1-gen-2016 | Matrone, Antonio; Faranda, Alessio; Molinaro, Eleonora; Agate, Laura; Viola, David; Valerio, Laura; Giani, Carlotta; Liborio, Torregrossa; Piaggi, Paolo; Vitti, Paolo; Elisei, Rossella | |
| 5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I | 1-gen-2015 | Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R. | |
| Active Surveillance In Papillary Thyroid Microcarcinomas (PMCS): A 2 Years Follow Up (FU) At A Single Center | 1-gen-2017 | Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Marcocci, Claudio; Vitti, Paolo; Elisei, Rossella; Molinaro, Eleonora | |
| Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at one single Italian center | 1-gen-2020 | Molinaro, Eleonora; Campopiano, Maria Cristina; Pieruzzi, Letizia; Matrone, Antonio; Agate, Laura; Bottici, Valeria; Viola, David; Cappagli, Virginia; Valerio, Laura; Giani, Carlotta; Puleo, Luciana; Lorusso, Loredana; Piaggi, Paolo; Torregrossa, Liborio; Basolo, Fulvio; Vitti, Paolo; Tuttle, R Michael; Elisei, Rossella | |
| Active surveillance in ret gene carriers belonging to families with multiple endocrine neoplasia | 1-gen-2021 | Prete, A.; Matrone, A.; Gambale, C.; Bottici, V.; Cappagli, V.; Romei, C.; Torregrossa, L.; Valerio, L.; Minaldi, E.; Campopiano, M. C.; Lorusso, L.; Agate, L.; Molinaro, E.; Viola, D.; Ramone, T.; Mule, C.; Ciampi, R.; Basolo, F.; Elisei, R. | |
| An idic(15) associated with POF (premature ovarian failure): Molecular cytogenetic definition of a case and review of the literature. | 1-gen-2012 | Bertini, V; Viola, David; Vitti, Paolo; Simi, P; Valetto, A. | |
| Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. | 1-gen-2013 | Xing, M; Alzahrani, As; Carson, Ka; Viola, David; Elisei, Rossella; Bendlova, B; Yip, L; Mian, C; Vianello, F; Tuttle, Rm; Robenshtok, E; Fagin, Ja; Puxeddu, E; Fugazzola, L; Czarniecka, A; Jarzab, B; O'Neill, Cj; Sywak, Ms; Lam, Ak; Riesco Eizaguirre, G; Santisteban, P; Nakayama, H; Tufano, Rp; Pai, Si; Zeiger, Ma; Westra, Wh; Clark, Dp; Clifton Bligh, R; Sidransky, D; Ladenson, Pw; Sykorova, V. | |
| Association between BRAF V600E mutation and recurrence of papillary thyroid cancer | 1-gen-2015 | Xing, Mingzhao; Alzahrani, Ali S.; Carson, Kathryn A.; Shong, Young Kee; Kim, Tae Yong; Viola, David; Elisei, Rossella; Bendlová, Bela; Yip, Linwah; Mian, Caterina; Vianello, Federica; Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.; Puxeddu, Efisio; Fugazzola, Laura; Czarniecka, Agnieszka; Jarzab, Barbara; O'Neill, Christine J.; Sywak, Mark S.; Lam, Alfred K.; Riesco Eizaguirre, Garcilaso; Santisteban, Pilar; Nakayama, Hirotaka; Clifton Bligh, Roderick; Tallini, Giovanni; Holt, Elizabeth H.; Sýkorová, Vlasta | |
| Association between BRAF V600E mutation and recurrence of papillary thyroid cancer | 1-gen-2015 | Xing, Mingzhao; Alzahrani, Ali S.; Carson, Kathryn A.; Shong, Young Kee; Kim, Tae Yong; Viola, David; Elisei, Rossella; Bendlová, Bela; Yip, Linwah; Mian, Caterina; Vianello, Federica; Tuttle, R. Michael; Robenshtok, Eyal; Fagin, James A.; Puxeddu, Efisio; Fugazzola, Laura; Czarniecka, Agnieszka; Jarzab, Barbara; O'Neill, Christine J.; Sywak, Mark S.; Lam, Alfred K.; Riesco Eizaguirre, Garcilaso; Santisteban, Pilar; Nakayama, Hirotaka; Clifton Bligh, Roderick; Tallini, Giovanni; Holt, Elizabeth H.; Sýkorová, Vlasta | |
| Biological and molecular markers for diagnosis, follow-up and prognosis of patients affected by thyroid cancer. | 1-gen-2008 | Elisei, Rossella; Viola, David; Pinchera, Aldo | |
| BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer | 1-gen-2018 | Wang, Fei; Zhao, Shihua; Shen, Xiaopei; Zhu, Guangwu; Liu, Rengyun; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K.; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O’Neill, Christine J.; Sywak, Mark S.; Clifton-Bligh, Roderick; Bendlova, Bela; Sýkorová, Vlasta; Wang, Yangang; Xing, Mingzhao | |
| BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment | 1-gen-2017 | Huang, Yueye; Qu, Shen; Zhu, Guangwu; Wang, Fei; Liu, Rengyun; Shen, Xiaopei; Viola, David; Elisei, Rossella; Puxeddu, Efisio; Fugazzola, Laura; Colombo, Carla; Jarzab, Barbara; Czarniecka, Agnieszka; Lam, Alfred K; Mian, Caterina; Vianello, Federica; Yip, Linwah; Riesco-Eizaguirre, Garcilaso; Santisteban, Pilar; O'Neill, Christine J; Xing, Mingzhao; Sywak, Mark S; Clifton-Bligh, Roderick; Bendlova, Bela; Sýkorová, Vlasta | |
| BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma | 1-gen-2020 | Kim, K. J.; Kim, S. G.; Tan, J.; Shen, X.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Xing, M. | |
| BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer | 1-gen-2021 | Tao, Y.; Wang, F.; Shen, X.; Zhu, G.; Liu, R.; Viola, D.; Elisei, R.; Puxeddu, E.; Fugazzola, L.; Colombo, C.; Jarzab, B.; Czarniecka, A.; Lam, A. K.; Mian, C.; Vianello, F.; Yip, L.; Riesco-Eizaguirre, G.; Santisteban, P.; O'Neill, C. J.; Sywak, M. S.; Clifton-Bligh, R.; Bendlova, B.; Sykorova, V.; Zhao, S.; Wang, Y.; Xing, M. | |
| BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study | 1-gen-2008 | Elisei, Rossella; Ugolini, C; Viola, David; Lupi, C; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio | |
| BRAF(V600E) mutations are correlated with a lower expression of both NIS and TPO mRNA expression in papillary thyroid cancer (PTC) | 1-gen-2007 | Romei, C; Ciampi, R; Faviana, Pinuccia; Basolo, Fulvio; Bottici, V; Viola, David; Berti, P; Molinaro, E; Pinchera, A; Elisei, Rossella | |
| BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study. | 1-gen-2007 | Viola, David; Ugolini, Clara; Lupi, Cristiana; Biagini, Agnese; Giannini, Riccardo; Romei, Cristina; Miccoli, Paolo; Pinchera, Aldo; Basolo, Fulvio; Elisei, Rossella | |
| BRAFV600E mutation is an indipendent predictive prognostic factor for persistent/recurrent disease in low risk differentiated Thyroid cancer patients: a 5 year follow-up study. | 1-gen-2012 | Viola, David; Torregrossa, L; Giannini, Riccardo; Ugolini, C; Bigini, A; Romei, C; Molinaro, Eleonora; Agate, Laura; Basolo, Fulvio; Pinchera, Aldo; Vitti, Paolo; Elisei, Rossella | |
| Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST | 1-gen-2021 | Lorusso, Loredana; Romei, Cristina; Piaggi, Paolo; Fustini, Chiara; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Pellegrini, Giovanni; Elisei, Rossella | |
| Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. | 1-gen-2013 | Viola, David; Cappagli, V; Elisei, Rossella |